The global brain monitoring market is estimated to be valued at USD 4,154.7 Mn in 2025 and is expected to reach USD 6,715.3 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 7.1% from 2025 to 2032.
The global brain monitoring market is expected to experience strong growth throughout the forecast period. This is mostly due to the increasing incidence of brain disorders and growing geriatric population across the globe.
Moreover, rise in demand for brain monitoring devices and an increase in research & development worldwide are expected to boost market growth. However, factors such as stringent regulatory framework for device approval and lack of skilled personnel to handle monitoring devices might hamper the market growth.
There is a continuous increase in new launches and approvals of advanced brain monitoring solutions globally. For instance, in June 2024, Zeto obtained FDA 510(k) clearance for its groundbreaking next-generation EEG brain monitoring product, ONE, from the U.S. FDA.
Zeto ONE is approved for EEG brain monitoring in homes, hospitals, ambulances, and even during air transport. Such new product launches and approvals are expected to boost the brain monitoring market growth during the projection period.
|
Current Event |
Description and its Impact |
|
AI and Machine Learning Integration in Healthcare Technology |
|
|
Global Aging Population and Neurological Disease Surge |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
AI is transforming the brain monitoring industry by enabling real-time analysis of complex neurological data. It integrates and interprets signals from various sources—such as EEG, ICP, and imaging—to detect patterns, predict complications, and support clinical decision-making. AI algorithms can identify subtle changes in brain activity that may be missed by human observers, allowing for earlier intervention and personalized treatment.
In September 2025, Moberg Analytics launched the Moberg Clinical Platform (MCP), its first product designed to address the complexity of brain function and the evolving nature of brain injury. Debuting at the Neurocritical Care Society Annual Meeting, MCP uses advanced analytics and AI to deliver real-time insights from multimodal data, helping clinicians make faster, more informed decisions in critical care.
Magnetoencephalograph segment is poised to exhibit strong growth during the forecast period. This is attributable to the rising use of magnetoencephalography due to its ability to provide highly accurate, real-time mapping of brain activity.
Magnetoencephalography (MEG) is an advanced, non-invasive method used to evaluate and record the brain while it is actively functioning. It is gaining traction due to its high precision as well as ability to capture real-time brain activity.
MEG offers superior spatial and temporal resolution, enabling clinicians to pinpoint abnormal brain activity with greater precision. This makes it especially valuable in diagnosing and managing neurological conditions like epilepsy, brain tumors, and traumatic brain injuries, where accurate brain mapping is critical for treatment planning.
Additionally, growing adoption of MEG in research and clinical settings is further driving segment growth. Its ability to assess functional brain networks non-invasively has expanded its use in neurology and cognitive neuroscience studies.
A recent development highlighting MEG’s growing popularity is the €2 Mn wearable MEG scanner introduced at Trinity College Dublin in September 2025. This innovative system uses optically pumped magnetometers (OPMs) to capture real-time brain activity with high precision, helping detect neurological disorders like epilepsy, dementia, and ADHD early.
Parkinson’s disease segment is expected to dominate the brain monitoring industry during the assessment period. This can be attributed to increasing prevalence of Parkinson’s disease worldwide.
There is a spike in neurological conditions like Parkinson’s disease globally. These disorders often require continuous and precise brain monitoring for effective diagnosis and management, thereby fueling demand for brain monitoring devices.
According to researchers, the number of people living with Parkinson’s disease is expected to reach about 25.2 million by 2050. This anticipated increase in Parkinson’s disease is slated to boost growth of the brain monitoring market during the assessment period.
To learn more about this report, Download Free Sample
North America currently dominates the global brain monitoring industry, accounting for a prominent market share of 42.5%. This can be attributed to increasing incidence of brain disorders, such as Parkinson’s disease, and advancements in brain monitoring technologies.
According to the Parkinson’s Foundation, nearly one million people in the U.S. are living with PD (Parkinson's disease), and this number is expected to reach 1.2 million by 2032. This high disease burden is expected to uplift demand for brain monitoring solutions in the region.
Brain monitoring techniques allow researchers and physicians to study human activities, brain-computer interfaces, and brain disorders. High demand, along with ongoing technology improvements and more healthcare spending, is set to strengthen North America’s leading position in the brain monitoring market.
Europe market is poised to witness robust growth during the assessment period. This is due to rising prevalence of brain disorders, growing geriatric population in the region, and increasing support from governments and organizations like Parkinson's Europe.
Parkinson’s disease is highly individual, with symptoms varying from person to person. This necessitates a personalized approach to treatment and care, making brain monitoring essential for effective disease management.
The U.S. brain monitoring market is expected to grow steadily due to rising awareness about brain health and neurological disorders. Hospitals, clinics, and research centers in the nation are increasingly adopting advanced monitoring technologies.
There is also an increase in government and private initiatives aimed at promoting early diagnosis and treatment of neurological conditions. For instance, in 2025, the U.S. Department of Defense expanded funding for wearable brain-monitoring technologies for traumatic brain injury (TBI) detection in soldiers and veterans. This is slated to boost sales of brain monitoring technologies in the nation during the forecast period.
Technological advancements like wearable brain monitoring devices and AI-based diagnostic tools are gaining traction. Similarly, rising interest in minimally invasive and non-invasive brain monitoring devices will bode well for the market.
The UK market is projected to exhibit strong growth during the assessment period. Increasing focus on patient care, early detection of brain diseases, and growing healthcare research activities are driving demand.
Rising investments in healthcare infrastructure and increasing government funding for neurological research are expected to boost the brain monitoring market growth. Moreover, demand for minimally invasive and home-based brain monitoring solutions is growing in the nation as patients and healthcare providers look for more convenient and efficient care options.
A notable example is the launch of the MinderCare service by Imperial College Healthcare NHS Trust in July 2025. This service offers remote, at-home monitoring for people living with dementia. This shows that the UK is a promising market for home-based brain monitoring solutions.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 4,154.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.1% | 2032 Value Projection: | USD 6,715.3 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Nonin Medical Inc., Koninklijke Philips NV, Cadwell Laboratories, Elekta AB, Masimo Corporation, Nihon Kohden Corporation, Compumedics, Integra LifeSciences, Medtronic PLC, Natus Medical Incorporated, and Advanced Brain Monitoring Inc., among others. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
One of the key factors expected to augment growth of the global brain monitoring market over the forecast period is the rising incidence of brain disorders across the world. According to the World Health Organization (WHO), the prevalence of PD has doubled globally in the past 25 years, with global estimates in 2019 showing around 8.5 million individuals living with PD.
This surge in Parkinson’s disease incidence is expected to drive demand for brain monitoring solutions during the assessment period. Brain monitoring is often used to evaluate several types of brain disorders.
Another factor driving global brain monitoring market growth is the growing geriatric population around the world. According to WHO, more than 20% of adults over the age of 60 suffer from a mental or neurological disorder, and such disorders account for 6.6% of all disability in people over the age of 60.
By 2030, one in six people around the world will be aged 60 years or over, and by 2050, the world’s population of people aged 60 years and older will double (2.1 billion). This, in turn, has increased the demand for brain monitoring solutions worldwide.
Demand for non-invasive and minimally invasive devices is increasing rapidly. This is due to expanding therapeutic applications of brain monitoring devices. For instance, use of wearable brain sensors helps differentiate cognitive states in many neurodegenerative conditions.
Nowadays, wireless headsets allow readings to be done in a completely non-invasive way and, in some cases, assess patients from the comfort of their homes. This trend is expected to continue over the forecast period, driving the growth of the market.
Increasing demand for brain monitoring devices across the globe is expected to provide significant growth opportunities for market players. For instance, brain monitoring devices help check brain activity, detect abnormal patterns, and track electrical signals in the brain. This makes them essential for diagnosing and managing neurological conditions.
In January 2022, iMediSync launched its first therapeutic device, iSyncWave, which integrates both EEG brain mapping and light-emitting diode (LED) therapy. The device uses high-quality dry EEG sensors that autofit to various head sizes and shapes, following the international 10–20 system, and is equipped with a sex- and age-matched normative EEG database.
Increasing research and development worldwide is also expected to offer lucrative growth opportunities for companies. For instance, in November 2022, EMOTIV and X-trodes announced a collaboration on a first-of-its-kind solution for simultaneous brain and physiological measurement outside the laboratory setting.
Wearable electrode patches provide improved accuracy and flexibility for researchers measuring brain and physiological signals in real-world environments, expanding possibilities for clinical studies. This, in turn, is expected to aid the growth of the global brain monitoring market.
Share
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
